General American Investors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-55,000
Closed -$5.19M 72
2019
Q1
$5.19M Sell
55,000
-100,000
-65% -$8.75M 0.51% 53
2018
Q4
$9.93M Sell
155,000
-10,000
-6% -$738K 1.04% 41
2018
Q3
$14.8M Hold
165,000
1.27% 33
2018
Q2
$13.1M Hold
165,000
1.19% 36
2018
Q1
$14.7M Hold
165,000
1.4% 28
2017
Q4
$17.2M Buy
165,000
+10,000
+6% +$1.13M 1.67% 26
2017
Q3
$22.6M Sell
155,000
-10,000
-6% -$1.36M 2.15% 12
2017
Q2
$21.4M Hold
165,000
2.17% 16
2017
Q1
$20.5M Hold
165,000
2.01% 17
2016
Q4
$19.1M Sell
165,000
-25,000
-13% -$2.78M 1.93% 19
2016
Q3
$19.9M Hold
190,000
2.03% 19
2016
Q2
$18.7M Hold
190,000
1.95% 19
2016
Q1
$19M Buy
190,000
+10,000
+6% +$1.03M 1.96% 22
2015
Q4
$21.6M Hold
180,000
1.98% 20
2015
Q3
$19.5M Sell
180,000
-20,000
-10% -$2.48M 1.76% 22
2015
Q2
$23.1M Hold
200,000
1.9% 21
2015
Q1
$23.1M Hold
200,000
1.9% 24
2014
Q4
$22.4M Hold
200,000
1.79% 28
2014
Q3
$19M Hold
200,000
1.51% 32
2014
Q2
$17.2M Hold
200,000
1.4% 36
2014
Q1
$14M Hold
200,000
1.17% 40
2013
Q4
$16.9M Hold
200,000
1.37% 34
2013
Q3
$15.4M Hold
200,000
1.34% 36
2013
Q2
$11.7M Buy
+200,000
New +$12M 1.06% 43

Other funds holding CELG

General American Investors's CELG Position: Q2 2019 in Review

General American Investors sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 55,000 shares — an estimated $5.19M sold.

General American Investors first reported a position in CELG in Q2 2013 and held it in 24 quarters. The position peaked at $23.1M in Q2 2015. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • General American Investors reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • General American Investors sold 55,000 Celgene Corp shares in Q2 2019, an estimated $5.19M.
  • General American Investors first reported a position in Celgene Corp in Q2 2013 and held it in 24 quarters.
  • General American Investors's Celgene Corp position peaked at $23.1M in Q2 2015.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on General American Investors's 13F filing for Q2 2019, filed 2 Aug 2019.